{"gene":"PF3D7_0207600","run_date":"2026-09-07T10:55:51","timeline":{"discoveries":[{"year":2002,"finding":"SERA5 (PF3D7_0207600) is essential for the asexual erythrocytic cycle of P. falciparum: repeated attempts to disrupt the SERA5 gene by homologous recombination failed, while genes at the periphery of the SERA cluster on chromosome 2 could be disrupted, indicating SERA5 is indispensable for blood-stage parasite maintenance.","method":"Targeted gene disruption by homologous recombination (loss-of-function genetics)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple independent gene-disruption attempts across the full SERA family in the same study, replicated in a follow-up paper (PMID:17893128) that confirmed SERA5 alone remained refractory to deletion","pmids":["12228245","17893128"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2002,"finding":"SERA5 protein localises within the parasitophorous vacuole of trophozoite- and schizont-stage intraerythrocytic parasites, as demonstrated by indirect immunofluorescence microscopy with SERA5-specific antibodies.","method":"Indirect immunofluorescence microscopy with specific polyclonal antibodies","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 3 / Strong — single method (IFA) but replicated independently (PMID:12228245, PMID:13679369, PMID:22984267)","pmids":["12244052","12228245"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2003,"finding":"The central papain-like enzyme domain of SERA5 possesses serine protease activity: a recombinant form processed substrates downstream of aromatic residues (chymotrypsin-like specificity), and this activity was abolished by the serine protease inhibitor 3,4-diisocoumarin. The canonical catalytic Cys of papain is replaced by Ser596 in SERA5.","method":"Recombinant protein expression, refolding, in vitro protease activity assay, inhibitor studies","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro reconstitution with inhibitor validation in a single study; contradicted by PMID:25599609 which found no detectable protease activity with the native Ser596-containing protein","pmids":["13679369"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2008,"finding":"SERA5 is proteolytically processed by PfSUB1 (subtilisin-family serine protease) and DPAP3 (cysteine protease dipeptidyl peptidase 3) just prior to erythrocyte rupture; pharmacological inhibition of either PfSUB1 or DPAP3 blocked SERA5 processing and was correlated with a block in parasite egress.","method":"Chemical genetic screen with covalent protease inhibitor library; immunoblot analysis of SERA5 processing in inhibitor-treated schizonts","journal":"Nature chemical biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — chemical genetics plus biochemical readout of substrate processing; independently supported by Ca2+-chelation experiments (PMID:23217145) and conditional KO studies (PMID:28683142)","pmids":["18246061","23217145"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"finding":"Crystal structure of the central protease-like domain of SERA5 was solved, revealing: (1) Ser596 occupies the position of the active-site Cys; (2) the active-site architecture is not conducive to canonical cysteine-protease substrate binding; (3) Asp594 restricts substrate access; (4) the S2 specificity pocket is occluded by Tyr735. These structural anomalies are consistent with impaired/absent protease activity.","method":"X-ray crystallography","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure with functional interpretation; independently corroborated by revised 1.2 Å structure (PMID:32955133)","pmids":["19591843","32955133"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"finding":"In P. berghei, the two serine-type SERA orthologues (PbSERA1 and PbSERA2) display differential expression during late merozoite formation and localise to the parasitophorous vacuole, as shown by antibody localisation and in vivo mCherry fluorescent tagging. Single and double gene knockouts of P. berghei serine-type SERAs progressed normally through the full parasite life cycle, indicating non-vital roles in vivo in this rodent malaria model.","method":"Fluorescent protein tagging (mCherry), antibody localisation, targeted gene replacement (KO)","journal":"Cellular microbiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two orthogonal methods (live imaging and KO genetics) in one study, but findings are in P. berghei orthologues, not directly in PfSERA5","pmids":["20039882"],"is_preprint":false,"attribution":[{"species":"Plasmodium berghei","strain":""}]},{"year":2012,"finding":"Chelation of intracellular Ca2+ in P. falciparum schizonts with BAPTA-AM blocks discharge of PfSUB1 from merozoite exonemes into the parasitophorous vacuole, which in turn prevents proteolytic processing of SERA5 and blocks parasitophorous vacuolar membrane (PVM) rupture and merozoite egress.","method":"Time-lapse video microscopy, intracellular Ca2+ chelation (BAPTA-AM), phospholipase C inhibition, immunoblot of SERA5 processing","journal":"Cellular microbiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple chemical perturbations with defined biochemical readout (SERA5 processing) and cell-biological phenotype in a single study","pmids":["23217145"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2013,"finding":"SERA5 is present on the surface of sporozoites as well as merozoites: the processed 47 kDa N-terminal fragment (P47) was detected in sporozoites by Western blotting for the first time, using monoclonal antibodies raised against SERA5 N-terminal peptide FB-23.","method":"Western blotting, indirect immunofluorescence assay with monoclonal antibodies","journal":"Peptides","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single-lab detection by two methods (WB and IFA); limited functional follow-up","pmids":["17875342"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2013,"finding":"SERA5 (P47 fragment) and SERA4 are shed from the merozoite surface at the tight junction during erythrocyte invasion, as demonstrated by real-time imaging and processing assays during live invasion events.","method":"Sequential immunoblot analysis and real-time live imaging of merozoite invasion","journal":"Infection and immunity","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — real-time invasion imaging plus biochemical processing data in a single study","pmids":["24218484"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2015,"finding":"SERA5 plays an indispensable non-enzymatic role in the P. falciparum asexual blood-stage life cycle: (1) no proteolytic activity was detected from parasite-derived or recombinant Ser596-containing SERA5; (2) substitution of Ser596 with Ala by targeted homologous recombination had no phenotypic consequence; (3) substitution of Ser596 with Cys yielded an active recombinant cysteine protease, showing the domain can bind peptide substrate but the native Ser cannot catalyse cleavage; (4) SERA5 could not be truncated or C-terminally tagged, establishing structural integrity of the full-length protein as essential.","method":"In vitro protease activity assay, site-directed mutagenesis of recombinant protein, targeted homologous recombination (Ser596Ala, Ser596Arg knock-in, internal tag insertion, C-terminal tag), parasite phenotyping","journal":"Molecular microbiology","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution (recombinant enzyme), active-site mutagenesis, and multiple in-parasite genetic manipulations in one rigorous study; mutant without catalytic Ser has no phenotype, definitively ruling out enzymatic function","pmids":["25599609"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2017,"finding":"Conditional DiCre-mediated disruption of the SERA5 gene caused premature host cell rupture and failure of daughter merozoites to efficiently disseminate (retained within residual bounding membranes), demonstrating that SERA5 is a regulator of egress kinetics and efficiency. Complementation with wild-type SERA5 reversed the defect, whereas a processing-refractory SERA5 mutant failed to rescue, proving that SUB1-mediated proteolytic processing of SERA5 is required for its function. SERA5 was not required for poration or vesiculation of the host cell membrane, but the premature rupture phenotype required cysteine protease activity.","method":"Conditional DiCre gene deletion, genetic complementation, processing-refractory mutant expression, live imaging, invasion assay, cysteine protease inhibitor treatment","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with complementation and separation-of-function mutant, multiple orthogonal methods, single rigorous study","pmids":["28683142"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2018,"finding":"Vitronectin (VTN) from host serum directly binds to a 20-residue region in the C-terminal portion of the P47/SE36 N-terminal domain of SERA5; VTN co-localises with SERA5 P47 on schizont and merozoite surfaces; VTN bound to SE36 prevented phagocytosis of SE36-coated beads by THP-1 macrophages, suggesting SERA5 mediates molecular camouflage of merozoites against host immunity.","method":"Serum protein screening, direct binding assay, co-localisation (IFA), phagocytosis assay with THP-1 cells","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding assay plus co-localisation plus functional phagocytosis readout, single lab","pmids":["29567995"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2018,"finding":"SERA5 is phosphorylated prior to merozoite egress; calcium-dependent protein kinase 1 (PfCDPK1) physically associates with SERA5 (co-immunoprecipitation, co-sedimentation, co-immunolocalisation) and phosphorylates SERA5 in vitro in a Ca2+-dependent manner, enhancing its proteolytic activity; the PfCDPK1 inhibitor purfalcamine blocked SERA5 phosphorylation and activation both in vitro and in schizonts, blocking egress.","method":"Immunoprecipitation + MS identification of PfCDPK1, co-sedimentation, co-immunoprecipitation, co-immunolocalisation, in vitro kinase assay, kinase inhibitor (purfalcamine) treatment, egress assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP plus in vitro kinase assay plus inhibitor phenotype; single lab; note tension with PMID:25599609 finding no protease activity from native SERA5","pmids":["29716996"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2019,"finding":"SERA5 physically interacts with the pseudokinase PfpTKL via its SAM motif: recombinant PfpTKL SAM domain pulled down SERA5 from P. falciparum lysate, establishing SERA5 as a binding partner of this scaffolding pseudokinase in the parasitophorous vacuole context.","method":"Pulldown / co-immunoprecipitation of native parasite lysate with recombinant domain","journal":"Scientific reports","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP/pulldown, single lab, no reciprocal confirmation or functional follow-up for the SERA5 interaction specifically","pmids":["31148576"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2020,"finding":"The crystal structure of the SERA5 pseudo-zymogen (enzyme domain plus cognate prodomain, PfSERA5PE) was solved to 2.2 Å resolution, and the isolated enzyme domain (PfSERA5E) was refined to 1.2 Å. The prodomain occludes the archetypal papain-like catalytic triad cleft in the same reverse orientation as conventional prodomains, consistent with SERA5 being maintained in an inactive zymogen-like state.","method":"X-ray crystallography (1.2 Å and 2.2 Å resolution structures)","journal":"Protein science : a publication of the Protein Society","confidence":"High","confidence_rationale":"Tier 1 / Moderate — high-resolution crystal structures of both the isolated domain and the prodomain-bound form in a single study, providing definitive structural evidence for the inactive pseudo-zymogen state","pmids":["32955133"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2007,"finding":"Deletion of SERA4 in P. falciparum resulted in a twofold compensatory increase in SERA5 mRNA levels, providing functional genetic evidence that SERA5 expression is regulated in response to loss of a related serine-type family member and is consistent with partial functional redundancy between SERA4 and SERA5.","method":"Gene knockout by homologous recombination, quantitative RT-PCR of SERA5 mRNA in SERA4-null parasites","journal":"Infection and immunity","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis (KO) with quantitative mRNA measurement; single lab but clear mechanistic link between SERA4 deletion and SERA5 upregulation","pmids":["17893128"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2008,"finding":"A 14-residue disulfide-bonded cyclic peptide (SBP1) identified by phage display against the SERA5 enzyme domain crosses both the erythrocyte and parasitophorous vacuole membranes and accumulates within the PV; treatment of parasite cultures with SBP1 compromised late-stage parasite development; SBP1 and SERA5 were also detected in the parasite cytosol, indicating parasite plasma membrane compromise, implicating the SERA5 enzyme domain in regulation of intraerythrocytic development.","method":"Phage display peptide selection, biochemical binding characterisation, parasite growth inhibition assay, immunolocalisation of peptide and SERA5","journal":"Infection and immunity","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — phage display plus cell biology plus localisation; indirect evidence for function; single lab","pmids":["18591232"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2014,"finding":"Protective epitopes of SERA5 recognised by inhibitory antibodies from naturally immune Ugandan adults reside in the intrinsically disordered N-terminal octamer-repeat and serine-rich regions; affinity-purified antibodies against these regions displayed high antibody-dependent cellular inhibition (ADCI) activity; spectroscopic and computational analysis confirmed these N-terminal regions are structurally unstructured.","method":"Synthetic peptide epitope mapping, affinity purification of antibodies, ADCI assay, structural analysis (spectroscopy + structure prediction)","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional ADCI assay combined with structural characterisation; single lab","pmids":["24886718"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2012,"finding":"Peptides derived from the C-terminal ~6 kDa region of the SERA5 active domain inhibit the recombinant SERA5 enzyme activity and delay parasite development in culture; molecular docking showed these peptides interact with the active site; the peptides co-localise with SERA5 in the parasite but do not affect SERA5 processing, indicating they act by direct active-site engagement.","method":"Synthetic peptide synthesis, in vitro enzyme inhibition assay, parasite growth/development assay, co-localisation (IFA), molecular docking","journal":"Biochimica et biophysica acta","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, in vitro enzyme data conflicts with PMID:25599609 showing no native protease activity; functional conclusion depends on contested activity claim","pmids":["24769454"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2012,"finding":"The SERA5 prodomain (21.9 kDa N-terminal subdomain of the 50.8 kDa central domain) inhibits parasite development when added exogenously to parasite cultures at nanomolar concentrations, causing a significant delay in schizont-to-ring transition; a heptapeptide from its C-terminus (DNSDNMF) shows the same effect at ~1000-fold higher concentration and interacts with the catalytic domain, suggesting the prodomain regulates SERA5 activity.","method":"Recombinant prodomain production (E. coli), parasite culture growth inhibition assay, peptide interaction assay","journal":"PloS one","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single method for each readout; functional interpretation partially depends on disputed protease activity of SERA5","pmids":["22291957"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2011,"finding":"The structure of the P. berghei ICP C-terminal inhibitory domain in complex with falcipain-2 shows that the active-site architecture of SERA5 (serine-repeat antigen 5) is incompatible with ICP binding, explaining why the SERA5 protease-like domain is not a target for ICP-class cysteine protease inhibitors.","method":"X-ray crystallography (2.6 Å) of PbICP-C/falcipain-2 complex with structural inference about SERA5","journal":"Structure (London, England : 1993)","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — high-quality crystal structure provides mechanistic explanation for SERA5 not being an ICP substrate; inference about SERA5 is structural/computational, not directly experimental on SERA5 itself","pmids":["21742259"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"current_model":"SERA5 (PF3D7_0207600) is an abundant parasitophorous-vacuole protein essential for the asexual blood-stage life cycle of P. falciparum that functions non-enzymatically despite possessing a papain-like domain: it carries a non-catalytic Ser596 in place of the active-site Cys, exhibits no detectable protease activity in its native form, and adopts a pseudo-zymogen fold in which the prodomain occludes the active-site cleft; its essential role is to regulate the kinetics and efficiency of merozoite egress from the host erythrocyte, a function that requires PfSUB1-mediated proteolytic processing of SERA5 itself and is genetically separable from any enzymatic activity, while SERA5 also participates in molecular camouflage of merozoites by recruiting host vitronectin and is phosphorylated by PfCDPK1 in a Ca2+-dependent manner prior to egress."},"narrative":{"mechanistic_narrative":"SERA5 (PF3D7_0207600) is an abundant parasitophorous-vacuole protein that is essential for the asexual erythrocytic cycle of P. falciparum, where it functions to regulate the kinetics and efficiency of merozoite egress from the host erythrocyte [PMID:12228245, PMID:17893128, PMID:28683142]. It localises to the parasitophorous vacuole of trophozoite- and schizont-stage parasites [PMID:12244052, PMID:12228245] and possesses a central papain-like domain that is catalytically dead in its native form: the canonical active-site Cys is replaced by Ser596, no protease activity is detectable from native SERA5, and crystal structures reveal a pseudo-zymogen fold in which the prodomain occludes the active-site cleft and further residues (Asp594, Tyr735) restrict substrate access [PMID:19591843, PMID:32955133, PMID:25599609]. The essential role of SERA5 is non-enzymatic and genetically separable from any catalytic activity, since a Ser596Ala knock-in has no phenotype while full-length structural integrity is required [PMID:25599609]. SERA5 function depends on proteolytic maturation: it is cleaved by PfSUB1 (and DPAP3) discharged into the vacuole just before rupture in a Ca2+-dependent manner, and a processing-refractory mutant fails to complement the egress defect of a conditional SERA5 knockout, which produces premature host-cell rupture and merozoites trapped within residual membranes [PMID:18246061, PMID:23217145, PMID:28683142]. Beyond egress, the processed P47 N-terminal fragment appears on the merozoite and sporozoite surface and recruits host vitronectin, blocking macrophage phagocytosis and implicating SERA5 in molecular camouflage against host immunity [PMID:17875342, PMID:29567995], and SERA5 is phosphorylated by PfCDPK1 in a Ca2+-dependent manner prior to egress [PMID:29716996]. In the P. berghei rodent-malaria model the serine-type SERA orthologues localise to the parasitophorous vacuole but are individually and jointly dispensable for the life cycle [PMID:20039882].","teleology":[{"year":2002,"claim":"Establishing whether SERA5 is required at all for blood-stage parasites: repeated failure to disrupt the gene, while flanking SERA-cluster genes were deletable, defined SERA5 as indispensable for the asexual erythrocytic cycle.","evidence":"Targeted gene disruption by homologous recombination across the SERA cluster","pmids":["12228245","17893128"],"confidence":"High","gaps":["Refractoriness to deletion does not reveal which molecular function is essential","Does not distinguish an enzymatic from a structural/regulatory role"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2002,"claim":"Localising SERA5 to define its site of action: it resides in the parasitophorous vacuole of trophozoite/schizont-stage parasites, placing it in the compartment where egress is executed.","evidence":"Indirect immunofluorescence microscopy with specific antibodies","pmids":["12244052","12228245"],"confidence":"Medium","gaps":["IFA alone does not resolve sub-vacuolar distribution","Does not establish molecular partners in the vacuole"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2003,"claim":"Testing whether the papain-like domain is a functional enzyme: a refolded recombinant domain showed inhibitor-sensitive chymotrypsin-like serine protease activity, initially framing SERA5 as an active protease despite the Cys-to-Ser596 substitution.","evidence":"Recombinant expression, refolding, in vitro protease assay with serine-protease inhibitor","pmids":["13679369"],"confidence":"Medium","gaps":["Activity was from a refolded recombinant form, not native protein","Later contradicted by studies finding no activity from native Ser596-containing SERA5"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2008,"claim":"Connecting SERA5 to the egress machinery: chemical-genetic inhibition showed SERA5 is processed by PfSUB1 and DPAP3 immediately before rupture, and blocking this processing correlated with a block in egress.","evidence":"Covalent protease-inhibitor library screen with immunoblot of SERA5 processing","pmids":["18246061","23217145"],"confidence":"High","gaps":["Correlation of processing with egress did not prove processed SERA5 is functionally required","Cleavage sites and fate of fragments not fully defined here"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"claim":"Explaining the catalytic ambiguity structurally: the crystal structure showed Ser596 in the Cys position and an active-site architecture (Asp594, Tyr735 occlusion) incompatible with canonical cysteine-protease catalysis.","evidence":"X-ray crystallography of the central protease-like domain","pmids":["19591843","32955133"],"confidence":"High","gaps":["Structure alone cannot exclude non-canonical or regulated activity","Does not address the essential in vivo function"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2009,"claim":"Testing genetic essentiality of the family in a tractable in vivo model: P. berghei serine-type SERA orthologues localise to the PV but single and double knockouts complete the life cycle, showing these orthologues are non-vital in the rodent model.","evidence":"mCherry tagging, antibody localisation, and targeted gene replacement in P. berghei","pmids":["20039882"],"confidence":"Medium","gaps":["Findings are in P. berghei orthologues, not PfSERA5 directly","Species divergence in essentiality left unexplained"],"attribution":[{"species":"Plasmodium berghei","strain":""}]},{"year":2012,"claim":"Placing SERA5 processing within the Ca2+-triggered egress cascade: BAPTA-AM chelation blocked PfSUB1 discharge, preventing SERA5 processing and PVM rupture, positioning SERA5 cleavage downstream of a calcium signal.","evidence":"Time-lapse microscopy, Ca2+ chelation, PLC inhibition, immunoblot of SERA5 processing","pmids":["23217145"],"confidence":"Medium","gaps":["Does not define the direct trigger for PfSUB1 discharge","Single-study chemical perturbations"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2015,"claim":"Resolving whether SERA5's essential role is enzymatic: native and recombinant Ser596 SERA5 had no protease activity, a Ser596Ala knock-in was phenotypically silent, Ser596Cys restored recombinant activity, and the full-length protein could not be truncated/tagged — establishing an essential non-enzymatic, structurally intact role.","evidence":"In vitro activity assays, active-site mutagenesis, and multiple in-parasite genetic manipulations","pmids":["25599609"],"confidence":"High","gaps":["Does not define the precise molecular action of the intact protein","Leaves the mechanism by which structural integrity is needed unresolved"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2017,"claim":"Defining the physiological function directly: conditional deletion caused premature rupture and failure of merozoite dissemination; wild-type but not a processing-refractory mutant rescued, proving SERA5 regulates egress kinetics and requires SUB1-mediated processing.","evidence":"DiCre conditional knockout, complementation, processing-refractory mutant, live imaging, cysteine-protease inhibitor","pmids":["28683142"],"confidence":"High","gaps":["Molecular target of processed SERA5 during egress not identified","Why the premature-rupture phenotype requires cysteine protease activity is unresolved"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2018,"claim":"Identifying an immune-evasion function: the P47/SE36 fragment directly binds host vitronectin and co-localises with it on merozoite surfaces, and VTN binding blocked phagocytosis of SE36-coated beads, implicating SERA5 in molecular camouflage.","evidence":"Serum protein screening, direct binding, IFA co-localisation, THP-1 phagocytosis assay","pmids":["29567995"],"confidence":"Medium","gaps":["Camouflage shown with coated beads, not live parasites","In vivo relevance to immune evasion untested"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2018,"claim":"Linking SERA5 to calcium-dependent kinase signalling: PfCDPK1 physically associates with SERA5 and phosphorylates it Ca2+-dependently prior to egress, with kinase inhibition blocking both phosphorylation and egress.","evidence":"Reciprocal co-IP/co-sedimentation, MS, in vitro kinase assay, purfalcamine inhibition, egress assay","pmids":["29716996"],"confidence":"Medium","gaps":["Phosphosites on SERA5 not mapped","The claimed enhancement of proteolytic activity conflicts with evidence that native SERA5 has no protease activity"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2020,"claim":"Confirming the inactive state structurally: high-resolution structures of the isolated enzyme domain and the prodomain-bound pseudo-zymogen showed the prodomain occludes the catalytic cleft in the conventional reverse orientation, consistent with a maintained inactive zymogen-like state.","evidence":"X-ray crystallography at 1.2 Å (domain) and 2.2 Å (pseudo-zymogen)","pmids":["32955133"],"confidence":"High","gaps":["Whether or how the prodomain is removed in vivo is not defined","Does not connect the zymogen state to the egress-regulatory function"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":null,"claim":"The precise molecular mechanism by which processed, catalytically inactive SERA5 restrains egress timing and organizes merozoite dissemination — and its direct binding target(s) within the vacuole — remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No direct downstream effector or substrate of processed SERA5 identified","Functional meaning of PfCDPK1 phosphorylation and prodomain removal for egress not established","Species divergence in essentiality (dispensable in P. berghei, essential in P. falciparum) unexplained"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":[],"partners":["PFSUB1 (PROCESSING PROTEASE)","DPAP3 (PROCESSING PROTEASE)","PFCDPK1 (KINASE, PHOSPHORYLATES SERA5)","HOST VITRONECTIN (VTN)","PFPTKL PSEUDOKINASE (SAM-DOMAIN INTERACTION)"],"other_free_text":["Native SERA5 harbors a non-catalytic Ser596 in place of the papain active-site Cys; Ser596Cys restores activity in recombinant protein but Ser596Ala knock-in is phenotypically silent [#9].","Essential in P. falciparum asexual blood stage (refractory to disruption) but the serine-type SERA orthologues are dispensable in P. berghei [#0, #5].","Deletion of SERA4 raises SERA5 mRNA ~2-fold, indicating regulatory/redundancy relationship within the family [#15].","Inhibitory antibody epitopes and the vitronectin-binding site map to intrinsically disordered N-terminal octamer-repeat/serine-rich regions of the P47 fragment [#11, #17].","Peptide/prodomain reagents that engage the SERA5 domain delay parasite development [#16, #18, #19]; the enzyme-inhibition-based interpretations conflict with evidence that native SERA5 lacks protease activity.","Structural analysis indicates the SERA5 active-site architecture is incompatible with ICP-class cysteine protease inhibitor binding [#20]."]}},"prefetch_data":{},"corpus_meta":[{"pmid":"15582526","id":"PMC_15582526","title":"Cysteine proteases of malaria parasites.","date":"2004","source":"International journal for parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/15582526","citation_count":262,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"18246061","id":"PMC_18246061","title":"Identification of proteases that regulate erythrocyte rupture by the malaria parasite Plasmodium falciparum.","date":"2008","source":"Nature chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/18246061","citation_count":202,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23489321","id":"PMC_23489321","title":"Robust inducible Cre recombinase activity in the human malaria parasite Plasmodium falciparum enables efficient gene deletion within a single asexual erythrocytic growth cycle.","date":"2013","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/23489321","citation_count":171,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"12228245","id":"PMC_12228245","title":"A subset of Plasmodium falciparum SERA genes are expressed and appear to play an important role in the erythrocytic cycle.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12228245","citation_count":137,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["curated_ref"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"21660657","id":"PMC_21660657","title":"Falcipains and other cysteine proteases of malaria parasites.","date":"2011","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/21660657","citation_count":116,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"26458807","id":"PMC_26458807","title":"Recent advances in recombinant protein-based malaria vaccines.","date":"2015","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/26458807","citation_count":92,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfSERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"12244052","id":"PMC_12244052","title":"Serine repeat antigen (SERA5) is predominantly expressed among the SERA multigene family of Plasmodium falciparum, and the acquired antibody titers correlate with serum inhibition of the parasite growth.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12244052","citation_count":83,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"13679369","id":"PMC_13679369","title":"Enzymic, phylogenetic, and structural characterization of the unusual papain-like protease domain of Plasmodium falciparum SERA5.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/13679369","citation_count":77,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"28683142","id":"PMC_28683142","title":"The Plasmodium falciparum pseudoprotease SERA5 regulates the kinetics and efficiency of malaria parasite egress from host erythrocytes.","date":"2017","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/28683142","citation_count":73,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17893128","id":"PMC_17893128","title":"Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design.","date":"2007","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/17893128","citation_count":66,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"22984267","id":"PMC_22984267","title":"Proteolytic activation of the essential parasitophorous vacuole cysteine protease SERA6 accompanies malaria parasite egress from its host erythrocyte.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22984267","citation_count":62,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"24218484","id":"PMC_24218484","title":"Sequential processing of merozoite surface proteins during and after erythrocyte invasion by Plasmodium falciparum.","date":"2013","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/24218484","citation_count":60,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23724021","id":"PMC_23724021","title":"Phase 1b randomized trial and follow-up study in Uganda of the blood-stage malaria vaccine candidate BK-SE36.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23724021","citation_count":59,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"25599609","id":"PMC_25599609","title":"Plasmodium falciparum SERA5 plays a non-enzymatic role in the malarial asexual blood-stage lifecycle.","date":"2015","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/25599609","citation_count":53,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16474069","id":"PMC_16474069","title":"High titers of IgG antibodies against Plasmodium falciparum serine repeat antigen 5 (SERA5) are associated with protection against severe malaria in Ugandan children.","date":"2006","source":"The American journal of tropical medicine and hygiene","url":"https://pubmed.ncbi.nlm.nih.gov/16474069","citation_count":53,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"20493274","id":"PMC_20493274","title":"Evidences of protection against blood-stage infection of Plasmodium falciparum by the novel protein vaccine SE36.","date":"2010","source":"Parasitology international","url":"https://pubmed.ncbi.nlm.nih.gov/20493274","citation_count":53,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23217145","id":"PMC_23217145","title":"Ca(2+) -mediated exocytosis of subtilisin-like protease 1: a key step in egress of Plasmodium falciparum merozoites.","date":"2012","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/23217145","citation_count":51,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["serine repeat antigen 5","PfSERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23291928","id":"PMC_23291928","title":"TLR9 adjuvants enhance immunogenicity and protective efficacy of the SE36/AHG malaria vaccine in nonhuman primate models.","date":"2013","source":"Human vaccines & immunotherapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/23291928","citation_count":38,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"24886718","id":"PMC_24886718","title":"Protective epitopes of the Plasmodium falciparum SERA5 malaria vaccine reside in intrinsically unstructured N-terminal repetitive sequences.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24886718","citation_count":36,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"19591843","id":"PMC_19591843","title":"Structural insights into the protease-like antigen Plasmodium falciparum SERA5 and its noncanonical active-site serine.","date":"2009","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19591843","citation_count":35,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"20039882","id":"PMC_20039882","title":"The Plasmodium serine-type SERA proteases display distinct expression patterns and non-essential in vivo roles during life cycle progression of the malaria parasite.","date":"2009","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/20039882","citation_count":35,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17196675","id":"PMC_17196675","title":"Comparative transcriptomal analysis of isogenic Plasmodium falciparum clones of distinct antigenic and adhesive phenotypes.","date":"2006","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/17196675","citation_count":35,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"21718740","id":"PMC_21718740","title":"Plasmodium falciparum serine repeat antigen 5 (SE36) as a malaria vaccine candidate.","date":"2011","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/21718740","citation_count":33,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17609844","id":"PMC_17609844","title":"Phylogeny and evolution of the SERA multigene family in the genus Plasmodium.","date":"2007","source":"Journal of molecular evolution","url":"https://pubmed.ncbi.nlm.nih.gov/17609844","citation_count":31,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","PfSERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"21742259","id":"PMC_21742259","title":"Structural basis for the regulation of cysteine-protease activity by a new class of protease inhibitors in Plasmodium.","date":"2011","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/21742259","citation_count":31,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"18820076","id":"PMC_18820076","title":"Deletion of the Plasmodium falciparum merozoite surface protein 7 gene impairs parasite invasion of erythrocytes.","date":"2008","source":"Eukaryotic cell","url":"https://pubmed.ncbi.nlm.nih.gov/18820076","citation_count":30,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"22230587","id":"PMC_22230587","title":"Geographic differentiation of polymorphism in the Plasmodium falciparum malaria vaccine candidate gene SERA5.","date":"2012","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/22230587","citation_count":25,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"29567995","id":"PMC_29567995","title":"Molecular Camouflage of Plasmodium falciparum Merozoites by Binding of Host Vitronectin to P47 Fragment of SERA5.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29567995","citation_count":24,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"29716996","id":"PMC_29716996","title":"Calcium-dependent phosphorylation of Plasmodium falciparum serine repeat antigen 5 triggers merozoite egress.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29716996","citation_count":23,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5","PfSERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23653352","id":"PMC_23653352","title":"In Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compound.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23653352","citation_count":22,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfSERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"33012605","id":"PMC_33012605","title":"First-in-human randomised trial and follow-up study of Plasmodium falciparum blood-stage malaria vaccine BK-SE36 with CpG-ODN(K3).","date":"2020","source":"Vaccine","url":"https://pubmed.ncbi.nlm.nih.gov/33012605","citation_count":21,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"30579868","id":"PMC_30579868","title":"Associations between IgG reactivity to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) antigens and Burkitt lymphoma in Ghana and Uganda case-control studies.","date":"2018","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/30579868","citation_count":20,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"18591232","id":"PMC_18591232","title":"Inhibition of malaria parasite development by a cyclic peptide that targets the vital parasite protein SERA5.","date":"2008","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/18591232","citation_count":20,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"32252804","id":"PMC_32252804","title":"Characteristic features of the SERA multigene family in the malaria parasite.","date":"2020","source":"Parasites & vectors","url":"https://pubmed.ncbi.nlm.nih.gov/32252804","citation_count":18,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","PfSERA5","PbSERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"17875342","id":"PMC_17875342","title":"Antibodies elicited by a virosomally formulated Plasmodium falciparum serine repeat antigen-5 derived peptide detect the processed 47 kDa fragment both in sporozoites and merozoites.","date":"2007","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/17875342","citation_count":18,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"15306658","id":"PMC_15306658","title":"The serine repeat antigen (SERA) gene family phylogeny in Plasmodium: the impact of GC content and reconciliation of gene and species trees.","date":"2004","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/15306658","citation_count":18,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"24769454","id":"PMC_24769454","title":"Synthetic peptides derived from the C-terminal 6kDa region of Plasmodium falciparum SERA5 inhibit the enzyme activity and malaria parasite development.","date":"2014","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/24769454","citation_count":17,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5","PfSERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"16687669","id":"PMC_16687669","title":"Pigmented monocytes are negative correlates of protection against severe and complicated malaria in Ugandan children.","date":"2006","source":"The American journal of tropical medicine and hygiene","url":"https://pubmed.ncbi.nlm.nih.gov/16687669","citation_count":16,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"27703240","id":"PMC_27703240","title":"Antibody titres and boosting after natural malaria infection in BK-SE36 vaccine responders during a follow-up study in Uganda.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27703240","citation_count":16,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"29760216","id":"PMC_29760216","title":"Plasmodium falciparum MSP3 Exists in a Complex on the Merozoite Surface and Generates Antibody Response during Natural Infection.","date":"2018","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/29760216","citation_count":15,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"28202027","id":"PMC_28202027","title":"A novel Pfs38 protein complex on the surface of Plasmodium falciparum blood-stage merozoites.","date":"2017","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/28202027","citation_count":14,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"33918470","id":"PMC_33918470","title":"Assessment of Mixed Plasmodium falciparum sera5 Infection in Endemic Burkitt Lymphoma: A Case-Control Study in Malawi.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/33918470","citation_count":11,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5","PfSERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"37908361","id":"PMC_37908361","title":"Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37908361","citation_count":11,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"31148576","id":"PMC_31148576","title":"Plasmodium pseudo-Tyrosine Kinase-like binds PP1 and SERA5 and is exported to host erythrocytes.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31148576","citation_count":9,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"22291957","id":"PMC_22291957","title":"Inhibitory potential of prodomain of Plasmodium falciparum protease serine repeat antigen 5 for asexual blood stages of parasite.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22291957","citation_count":9,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"36119062","id":"PMC_36119062","title":"Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36119062","citation_count":9,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"21630256","id":"PMC_21630256","title":"Antibodies reactive to Plasmodium falciparum serine repeat antigen in children with Burkitt lymphoma from Ghana.","date":"2011","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21630256","citation_count":9,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23395684","id":"PMC_23395684","title":"Association of naturally acquired IgG antibodies against Plasmodium falciparum serine repeat antigen-5 with reduced placental parasitemia and normal birth weight in pregnant Ugandan women: a pilot study.","date":"2013","source":"Parasitology international","url":"https://pubmed.ncbi.nlm.nih.gov/23395684","citation_count":9,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"36993981","id":"PMC_36993981","title":"Plasmodium falciparum infection coinciding with the malaria vaccine candidate BK-SE36 administration interferes with the immune responses in Burkinabe children.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36993981","citation_count":8,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"18939502","id":"PMC_18939502","title":"[Malaria vaccine].","date":"2008","source":"Nihon rinsho. Japanese journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18939502","citation_count":5,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"28662682","id":"PMC_28662682","title":"Pooled-DNA sequencing identifies genomic regions of selection in Nigerian isolates of Plasmodium falciparum.","date":"2017","source":"Parasites & vectors","url":"https://pubmed.ncbi.nlm.nih.gov/28662682","citation_count":5,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"33032613","id":"PMC_33032613","title":"Age-dependent carriage of alleles and haplotypes of Plasmodium falciparum sera5, eba-175, and csp in a region of intense malaria transmission in Uganda.","date":"2020","source":"Malaria journal","url":"https://pubmed.ncbi.nlm.nih.gov/33032613","citation_count":4,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"27343834","id":"PMC_27343834","title":"Immunogenicity and protection from malaria infection in BK-SE36 vaccinated volunteers in Uganda is not influenced by HLA-DRB1 alleles.","date":"2016","source":"Parasitology international","url":"https://pubmed.ncbi.nlm.nih.gov/27343834","citation_count":4,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"32955133","id":"PMC_32955133","title":"Structure of the Plasmodium falciparum PfSERA5 pseudo-zymogen.","date":"2020","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/32955133","citation_count":4,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfSERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23485360","id":"PMC_23485360","title":"Plasmodium vivax: C-terminal diversity in the blood stage SERA genes from Indian field isolates.","date":"2013","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/23485360","citation_count":3,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","PvSERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"25976464","id":"PMC_25976464","title":"Plasmodium vivax: N-terminal diversity in the blood stage SERA genes from Indian isolates.","date":"2015","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/25976464","citation_count":3,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PvSERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"36590593","id":"PMC_36590593","title":"African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination.","date":"2022","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/36590593","citation_count":2,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"38101534","id":"PMC_38101534","title":"Immune tolerance caused by repeated P. falciparum infection against SE36 malaria vaccine candidate antigen and the resulting limited polymorphism.","date":"2023","source":"Parasitology international","url":"https://pubmed.ncbi.nlm.nih.gov/38101534","citation_count":2,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"30483336","id":"PMC_30483336","title":"Genetic Diversity in C-terminal of SERA5 Gene in the Blood Stage of Human Isolates of Plasmodium vivax in Sistan and Baluchistan, Iran.","date":"2018","source":"Iranian journal of parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/30483336","citation_count":1,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","PvSERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"26725489","id":"PMC_26725489","title":"In silico approach to ascertain the calcium dependent role of Plasmodium falciparum SERA5.","date":"2016","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/26725489","citation_count":1,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","PfSERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"28808204","id":"PMC_28808204","title":"Safety, immunogenicity, and cross-species protection of a plasmid DNA encoding Plasmodium falciparum SERA5 polypeptide, microbial epitopes and chemokine genes in mice and olive baboons.","date":"2017","source":"Journal of biomedical research","url":"https://pubmed.ncbi.nlm.nih.gov/28808204","citation_count":0,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"39448193","id":"PMC_39448193","title":"Plasmodium proteases and their role in development of Malaria vaccines.","date":"2024","source":"Advances in parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/39448193","citation_count":0,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"39185645","id":"PMC_39185645","title":"Therapeutic Targeting and Role of Cysteine Proteases in the Life Cycle of Malaria Parasite.","date":"2025","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39185645","citation_count":0,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"42431567","id":"PMC_42431567","title":"Bioinformatic analysis of Plasmodium knowlesi Serine Repeat Antigen 3 (SERA3) sequences for antimalarial peptide development.","date":"2026","source":"Acta tropica","url":"https://pubmed.ncbi.nlm.nih.gov/42431567","citation_count":0,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","PfSERA5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"24189556","id":"PMC_24189556","title":"[Development and application of next generation SE36 malaria vaccine formulated with a novel adjuvant: approach to travelers' vaccine].","date":"2013","source":"Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan","url":"https://pubmed.ncbi.nlm.nih.gov/24189556","citation_count":0,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["SERA5","serine repeat antigen 5"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":37837,"output_tokens":6113,"usd":0.102603,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13087,"output_tokens":5066,"usd":0.096043,"stage2_stop_reason":"end_turn"},"total_usd":0.198646,"stage1_batch_id":"msgbatch_01DbiymDmubkPpYvdbAu5a7V","stage2_batch_id":"msgbatch_012TbrWvMRH129T7PQ4SmvrJ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"SERA5 (PF3D7_0207600) is essential for the asexual erythrocytic cycle of P. falciparum: repeated attempts to disrupt the SERA5 gene by homologous recombination failed, while genes at the periphery of the SERA cluster on chromosome 2 could be disrupted, indicating SERA5 is indispensable for blood-stage parasite maintenance.\",\n      \"method\": \"Targeted gene disruption by homologous recombination (loss-of-function genetics)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple independent gene-disruption attempts across the full SERA family in the same study, replicated in a follow-up paper (PMID:17893128) that confirmed SERA5 alone remained refractory to deletion\",\n      \"pmids\": [\"12228245\", \"17893128\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"SERA5 protein localises within the parasitophorous vacuole of trophozoite- and schizont-stage intraerythrocytic parasites, as demonstrated by indirect immunofluorescence microscopy with SERA5-specific antibodies.\",\n      \"method\": \"Indirect immunofluorescence microscopy with specific polyclonal antibodies\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Strong — single method (IFA) but replicated independently (PMID:12228245, PMID:13679369, PMID:22984267)\",\n      \"pmids\": [\"12244052\", \"12228245\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The central papain-like enzyme domain of SERA5 possesses serine protease activity: a recombinant form processed substrates downstream of aromatic residues (chymotrypsin-like specificity), and this activity was abolished by the serine protease inhibitor 3,4-diisocoumarin. The canonical catalytic Cys of papain is replaced by Ser596 in SERA5.\",\n      \"method\": \"Recombinant protein expression, refolding, in vitro protease activity assay, inhibitor studies\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro reconstitution with inhibitor validation in a single study; contradicted by PMID:25599609 which found no detectable protease activity with the native Ser596-containing protein\",\n      \"pmids\": [\"13679369\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"SERA5 is proteolytically processed by PfSUB1 (subtilisin-family serine protease) and DPAP3 (cysteine protease dipeptidyl peptidase 3) just prior to erythrocyte rupture; pharmacological inhibition of either PfSUB1 or DPAP3 blocked SERA5 processing and was correlated with a block in parasite egress.\",\n      \"method\": \"Chemical genetic screen with covalent protease inhibitor library; immunoblot analysis of SERA5 processing in inhibitor-treated schizonts\",\n      \"journal\": \"Nature chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — chemical genetics plus biochemical readout of substrate processing; independently supported by Ca2+-chelation experiments (PMID:23217145) and conditional KO studies (PMID:28683142)\",\n      \"pmids\": [\"18246061\", \"23217145\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Crystal structure of the central protease-like domain of SERA5 was solved, revealing: (1) Ser596 occupies the position of the active-site Cys; (2) the active-site architecture is not conducive to canonical cysteine-protease substrate binding; (3) Asp594 restricts substrate access; (4) the S2 specificity pocket is occluded by Tyr735. These structural anomalies are consistent with impaired/absent protease activity.\",\n      \"method\": \"X-ray crystallography\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure with functional interpretation; independently corroborated by revised 1.2 Å structure (PMID:32955133)\",\n      \"pmids\": [\"19591843\", \"32955133\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In P. berghei, the two serine-type SERA orthologues (PbSERA1 and PbSERA2) display differential expression during late merozoite formation and localise to the parasitophorous vacuole, as shown by antibody localisation and in vivo mCherry fluorescent tagging. Single and double gene knockouts of P. berghei serine-type SERAs progressed normally through the full parasite life cycle, indicating non-vital roles in vivo in this rodent malaria model.\",\n      \"method\": \"Fluorescent protein tagging (mCherry), antibody localisation, targeted gene replacement (KO)\",\n      \"journal\": \"Cellular microbiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal methods (live imaging and KO genetics) in one study, but findings are in P. berghei orthologues, not directly in PfSERA5\",\n      \"pmids\": [\"20039882\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Chelation of intracellular Ca2+ in P. falciparum schizonts with BAPTA-AM blocks discharge of PfSUB1 from merozoite exonemes into the parasitophorous vacuole, which in turn prevents proteolytic processing of SERA5 and blocks parasitophorous vacuolar membrane (PVM) rupture and merozoite egress.\",\n      \"method\": \"Time-lapse video microscopy, intracellular Ca2+ chelation (BAPTA-AM), phospholipase C inhibition, immunoblot of SERA5 processing\",\n      \"journal\": \"Cellular microbiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple chemical perturbations with defined biochemical readout (SERA5 processing) and cell-biological phenotype in a single study\",\n      \"pmids\": [\"23217145\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SERA5 is present on the surface of sporozoites as well as merozoites: the processed 47 kDa N-terminal fragment (P47) was detected in sporozoites by Western blotting for the first time, using monoclonal antibodies raised against SERA5 N-terminal peptide FB-23.\",\n      \"method\": \"Western blotting, indirect immunofluorescence assay with monoclonal antibodies\",\n      \"journal\": \"Peptides\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single-lab detection by two methods (WB and IFA); limited functional follow-up\",\n      \"pmids\": [\"17875342\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SERA5 (P47 fragment) and SERA4 are shed from the merozoite surface at the tight junction during erythrocyte invasion, as demonstrated by real-time imaging and processing assays during live invasion events.\",\n      \"method\": \"Sequential immunoblot analysis and real-time live imaging of merozoite invasion\",\n      \"journal\": \"Infection and immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — real-time invasion imaging plus biochemical processing data in a single study\",\n      \"pmids\": [\"24218484\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SERA5 plays an indispensable non-enzymatic role in the P. falciparum asexual blood-stage life cycle: (1) no proteolytic activity was detected from parasite-derived or recombinant Ser596-containing SERA5; (2) substitution of Ser596 with Ala by targeted homologous recombination had no phenotypic consequence; (3) substitution of Ser596 with Cys yielded an active recombinant cysteine protease, showing the domain can bind peptide substrate but the native Ser cannot catalyse cleavage; (4) SERA5 could not be truncated or C-terminally tagged, establishing structural integrity of the full-length protein as essential.\",\n      \"method\": \"In vitro protease activity assay, site-directed mutagenesis of recombinant protein, targeted homologous recombination (Ser596Ala, Ser596Arg knock-in, internal tag insertion, C-terminal tag), parasite phenotyping\",\n      \"journal\": \"Molecular microbiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution (recombinant enzyme), active-site mutagenesis, and multiple in-parasite genetic manipulations in one rigorous study; mutant without catalytic Ser has no phenotype, definitively ruling out enzymatic function\",\n      \"pmids\": [\"25599609\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Conditional DiCre-mediated disruption of the SERA5 gene caused premature host cell rupture and failure of daughter merozoites to efficiently disseminate (retained within residual bounding membranes), demonstrating that SERA5 is a regulator of egress kinetics and efficiency. Complementation with wild-type SERA5 reversed the defect, whereas a processing-refractory SERA5 mutant failed to rescue, proving that SUB1-mediated proteolytic processing of SERA5 is required for its function. SERA5 was not required for poration or vesiculation of the host cell membrane, but the premature rupture phenotype required cysteine protease activity.\",\n      \"method\": \"Conditional DiCre gene deletion, genetic complementation, processing-refractory mutant expression, live imaging, invasion assay, cysteine protease inhibitor treatment\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with complementation and separation-of-function mutant, multiple orthogonal methods, single rigorous study\",\n      \"pmids\": [\"28683142\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Vitronectin (VTN) from host serum directly binds to a 20-residue region in the C-terminal portion of the P47/SE36 N-terminal domain of SERA5; VTN co-localises with SERA5 P47 on schizont and merozoite surfaces; VTN bound to SE36 prevented phagocytosis of SE36-coated beads by THP-1 macrophages, suggesting SERA5 mediates molecular camouflage of merozoites against host immunity.\",\n      \"method\": \"Serum protein screening, direct binding assay, co-localisation (IFA), phagocytosis assay with THP-1 cells\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding assay plus co-localisation plus functional phagocytosis readout, single lab\",\n      \"pmids\": [\"29567995\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SERA5 is phosphorylated prior to merozoite egress; calcium-dependent protein kinase 1 (PfCDPK1) physically associates with SERA5 (co-immunoprecipitation, co-sedimentation, co-immunolocalisation) and phosphorylates SERA5 in vitro in a Ca2+-dependent manner, enhancing its proteolytic activity; the PfCDPK1 inhibitor purfalcamine blocked SERA5 phosphorylation and activation both in vitro and in schizonts, blocking egress.\",\n      \"method\": \"Immunoprecipitation + MS identification of PfCDPK1, co-sedimentation, co-immunoprecipitation, co-immunolocalisation, in vitro kinase assay, kinase inhibitor (purfalcamine) treatment, egress assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP plus in vitro kinase assay plus inhibitor phenotype; single lab; note tension with PMID:25599609 finding no protease activity from native SERA5\",\n      \"pmids\": [\"29716996\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SERA5 physically interacts with the pseudokinase PfpTKL via its SAM motif: recombinant PfpTKL SAM domain pulled down SERA5 from P. falciparum lysate, establishing SERA5 as a binding partner of this scaffolding pseudokinase in the parasitophorous vacuole context.\",\n      \"method\": \"Pulldown / co-immunoprecipitation of native parasite lysate with recombinant domain\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP/pulldown, single lab, no reciprocal confirmation or functional follow-up for the SERA5 interaction specifically\",\n      \"pmids\": [\"31148576\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The crystal structure of the SERA5 pseudo-zymogen (enzyme domain plus cognate prodomain, PfSERA5PE) was solved to 2.2 Å resolution, and the isolated enzyme domain (PfSERA5E) was refined to 1.2 Å. The prodomain occludes the archetypal papain-like catalytic triad cleft in the same reverse orientation as conventional prodomains, consistent with SERA5 being maintained in an inactive zymogen-like state.\",\n      \"method\": \"X-ray crystallography (1.2 Å and 2.2 Å resolution structures)\",\n      \"journal\": \"Protein science : a publication of the Protein Society\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — high-resolution crystal structures of both the isolated domain and the prodomain-bound form in a single study, providing definitive structural evidence for the inactive pseudo-zymogen state\",\n      \"pmids\": [\"32955133\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Deletion of SERA4 in P. falciparum resulted in a twofold compensatory increase in SERA5 mRNA levels, providing functional genetic evidence that SERA5 expression is regulated in response to loss of a related serine-type family member and is consistent with partial functional redundancy between SERA4 and SERA5.\",\n      \"method\": \"Gene knockout by homologous recombination, quantitative RT-PCR of SERA5 mRNA in SERA4-null parasites\",\n      \"journal\": \"Infection and immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis (KO) with quantitative mRNA measurement; single lab but clear mechanistic link between SERA4 deletion and SERA5 upregulation\",\n      \"pmids\": [\"17893128\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"A 14-residue disulfide-bonded cyclic peptide (SBP1) identified by phage display against the SERA5 enzyme domain crosses both the erythrocyte and parasitophorous vacuole membranes and accumulates within the PV; treatment of parasite cultures with SBP1 compromised late-stage parasite development; SBP1 and SERA5 were also detected in the parasite cytosol, indicating parasite plasma membrane compromise, implicating the SERA5 enzyme domain in regulation of intraerythrocytic development.\",\n      \"method\": \"Phage display peptide selection, biochemical binding characterisation, parasite growth inhibition assay, immunolocalisation of peptide and SERA5\",\n      \"journal\": \"Infection and immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — phage display plus cell biology plus localisation; indirect evidence for function; single lab\",\n      \"pmids\": [\"18591232\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Protective epitopes of SERA5 recognised by inhibitory antibodies from naturally immune Ugandan adults reside in the intrinsically disordered N-terminal octamer-repeat and serine-rich regions; affinity-purified antibodies against these regions displayed high antibody-dependent cellular inhibition (ADCI) activity; spectroscopic and computational analysis confirmed these N-terminal regions are structurally unstructured.\",\n      \"method\": \"Synthetic peptide epitope mapping, affinity purification of antibodies, ADCI assay, structural analysis (spectroscopy + structure prediction)\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional ADCI assay combined with structural characterisation; single lab\",\n      \"pmids\": [\"24886718\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Peptides derived from the C-terminal ~6 kDa region of the SERA5 active domain inhibit the recombinant SERA5 enzyme activity and delay parasite development in culture; molecular docking showed these peptides interact with the active site; the peptides co-localise with SERA5 in the parasite but do not affect SERA5 processing, indicating they act by direct active-site engagement.\",\n      \"method\": \"Synthetic peptide synthesis, in vitro enzyme inhibition assay, parasite growth/development assay, co-localisation (IFA), molecular docking\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, in vitro enzyme data conflicts with PMID:25599609 showing no native protease activity; functional conclusion depends on contested activity claim\",\n      \"pmids\": [\"24769454\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The SERA5 prodomain (21.9 kDa N-terminal subdomain of the 50.8 kDa central domain) inhibits parasite development when added exogenously to parasite cultures at nanomolar concentrations, causing a significant delay in schizont-to-ring transition; a heptapeptide from its C-terminus (DNSDNMF) shows the same effect at ~1000-fold higher concentration and interacts with the catalytic domain, suggesting the prodomain regulates SERA5 activity.\",\n      \"method\": \"Recombinant prodomain production (E. coli), parasite culture growth inhibition assay, peptide interaction assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single method for each readout; functional interpretation partially depends on disputed protease activity of SERA5\",\n      \"pmids\": [\"22291957\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The structure of the P. berghei ICP C-terminal inhibitory domain in complex with falcipain-2 shows that the active-site architecture of SERA5 (serine-repeat antigen 5) is incompatible with ICP binding, explaining why the SERA5 protease-like domain is not a target for ICP-class cysteine protease inhibitors.\",\n      \"method\": \"X-ray crystallography (2.6 Å) of PbICP-C/falcipain-2 complex with structural inference about SERA5\",\n      \"journal\": \"Structure (London, England : 1993)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — high-quality crystal structure provides mechanistic explanation for SERA5 not being an ICP substrate; inference about SERA5 is structural/computational, not directly experimental on SERA5 itself\",\n      \"pmids\": [\"21742259\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"current_model\": \"SERA5 (PF3D7_0207600) is an abundant parasitophorous-vacuole protein essential for the asexual blood-stage life cycle of P. falciparum that functions non-enzymatically despite possessing a papain-like domain: it carries a non-catalytic Ser596 in place of the active-site Cys, exhibits no detectable protease activity in its native form, and adopts a pseudo-zymogen fold in which the prodomain occludes the active-site cleft; its essential role is to regulate the kinetics and efficiency of merozoite egress from the host erythrocyte, a function that requires PfSUB1-mediated proteolytic processing of SERA5 itself and is genetically separable from any enzymatic activity, while SERA5 also participates in molecular camouflage of merozoites by recruiting host vitronectin and is phosphorylated by PfCDPK1 in a Ca2+-dependent manner prior to egress.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SERA5 (PF3D7_0207600) is an abundant parasitophorous-vacuole protein that is essential for the asexual erythrocytic cycle of P. falciparum, where it functions to regulate the kinetics and efficiency of merozoite egress from the host erythrocyte [#0, #10]. It localises to the parasitophorous vacuole of trophozoite- and schizont-stage parasites [#1] and possesses a central papain-like domain that is catalytically dead in its native form: the canonical active-site Cys is replaced by Ser596, no protease activity is detectable from native SERA5, and crystal structures reveal a pseudo-zymogen fold in which the prodomain occludes the active-site cleft and further residues (Asp594, Tyr735) restrict substrate access [#4, #9, #14]. The essential role of SERA5 is non-enzymatic and genetically separable from any catalytic activity, since a Ser596Ala knock-in has no phenotype while full-length structural integrity is required [#9]. SERA5 function depends on proteolytic maturation: it is cleaved by PfSUB1 (and DPAP3) discharged into the vacuole just before rupture in a Ca2+-dependent manner, and a processing-refractory mutant fails to complement the egress defect of a conditional SERA5 knockout, which produces premature host-cell rupture and merozoites trapped within residual membranes [#3, #6, #10]. Beyond egress, the processed P47 N-terminal fragment appears on the merozoite and sporozoite surface and recruits host vitronectin, blocking macrophage phagocytosis and implicating SERA5 in molecular camouflage against host immunity [#7, #11], and SERA5 is phosphorylated by PfCDPK1 in a Ca2+-dependent manner prior to egress [#12]. In the P. berghei rodent-malaria model the serine-type SERA orthologues localise to the parasitophorous vacuole but are individually and jointly dispensable for the life cycle [#5].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing whether SERA5 is required at all for blood-stage parasites: repeated failure to disrupt the gene, while flanking SERA-cluster genes were deletable, defined SERA5 as indispensable for the asexual erythrocytic cycle.\",\n      \"evidence\": \"Targeted gene disruption by homologous recombination across the SERA cluster\",\n      \"pmids\": [\"12228245\", \"17893128\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Refractoriness to deletion does not reveal which molecular function is essential\", \"Does not distinguish an enzymatic from a structural/regulatory role\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Localising SERA5 to define its site of action: it resides in the parasitophorous vacuole of trophozoite/schizont-stage parasites, placing it in the compartment where egress is executed.\",\n      \"evidence\": \"Indirect immunofluorescence microscopy with specific antibodies\",\n      \"pmids\": [\"12244052\", \"12228245\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"IFA alone does not resolve sub-vacuolar distribution\", \"Does not establish molecular partners in the vacuole\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Testing whether the papain-like domain is a functional enzyme: a refolded recombinant domain showed inhibitor-sensitive chymotrypsin-like serine protease activity, initially framing SERA5 as an active protease despite the Cys-to-Ser596 substitution.\",\n      \"evidence\": \"Recombinant expression, refolding, in vitro protease assay with serine-protease inhibitor\",\n      \"pmids\": [\"13679369\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Activity was from a refolded recombinant form, not native protein\", \"Later contradicted by studies finding no activity from native Ser596-containing SERA5\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Connecting SERA5 to the egress machinery: chemical-genetic inhibition showed SERA5 is processed by PfSUB1 and DPAP3 immediately before rupture, and blocking this processing correlated with a block in egress.\",\n      \"evidence\": \"Covalent protease-inhibitor library screen with immunoblot of SERA5 processing\",\n      \"pmids\": [\"18246061\", \"23217145\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Correlation of processing with egress did not prove processed SERA5 is functionally required\", \"Cleavage sites and fate of fragments not fully defined here\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Explaining the catalytic ambiguity structurally: the crystal structure showed Ser596 in the Cys position and an active-site architecture (Asp594, Tyr735 occlusion) incompatible with canonical cysteine-protease catalysis.\",\n      \"evidence\": \"X-ray crystallography of the central protease-like domain\",\n      \"pmids\": [\"19591843\", \"32955133\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure alone cannot exclude non-canonical or regulated activity\", \"Does not address the essential in vivo function\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Testing genetic essentiality of the family in a tractable in vivo model: P. berghei serine-type SERA orthologues localise to the PV but single and double knockouts complete the life cycle, showing these orthologues are non-vital in the rodent model.\",\n      \"evidence\": \"mCherry tagging, antibody localisation, and targeted gene replacement in P. berghei\",\n      \"pmids\": [\"20039882\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Findings are in P. berghei orthologues, not PfSERA5 directly\", \"Species divergence in essentiality left unexplained\"],\n      \"attribution\": [{\"species\": \"Plasmodium berghei\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Placing SERA5 processing within the Ca2+-triggered egress cascade: BAPTA-AM chelation blocked PfSUB1 discharge, preventing SERA5 processing and PVM rupture, positioning SERA5 cleavage downstream of a calcium signal.\",\n      \"evidence\": \"Time-lapse microscopy, Ca2+ chelation, PLC inhibition, immunoblot of SERA5 processing\",\n      \"pmids\": [\"23217145\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not define the direct trigger for PfSUB1 discharge\", \"Single-study chemical perturbations\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Resolving whether SERA5's essential role is enzymatic: native and recombinant Ser596 SERA5 had no protease activity, a Ser596Ala knock-in was phenotypically silent, Ser596Cys restored recombinant activity, and the full-length protein could not be truncated/tagged — establishing an essential non-enzymatic, structurally intact role.\",\n      \"evidence\": \"In vitro activity assays, active-site mutagenesis, and multiple in-parasite genetic manipulations\",\n      \"pmids\": [\"25599609\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not define the precise molecular action of the intact protein\", \"Leaves the mechanism by which structural integrity is needed unresolved\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defining the physiological function directly: conditional deletion caused premature rupture and failure of merozoite dissemination; wild-type but not a processing-refractory mutant rescued, proving SERA5 regulates egress kinetics and requires SUB1-mediated processing.\",\n      \"evidence\": \"DiCre conditional knockout, complementation, processing-refractory mutant, live imaging, cysteine-protease inhibitor\",\n      \"pmids\": [\"28683142\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular target of processed SERA5 during egress not identified\", \"Why the premature-rupture phenotype requires cysteine protease activity is unresolved\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identifying an immune-evasion function: the P47/SE36 fragment directly binds host vitronectin and co-localises with it on merozoite surfaces, and VTN binding blocked phagocytosis of SE36-coated beads, implicating SERA5 in molecular camouflage.\",\n      \"evidence\": \"Serum protein screening, direct binding, IFA co-localisation, THP-1 phagocytosis assay\",\n      \"pmids\": [\"29567995\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Camouflage shown with coated beads, not live parasites\", \"In vivo relevance to immune evasion untested\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Linking SERA5 to calcium-dependent kinase signalling: PfCDPK1 physically associates with SERA5 and phosphorylates it Ca2+-dependently prior to egress, with kinase inhibition blocking both phosphorylation and egress.\",\n      \"evidence\": \"Reciprocal co-IP/co-sedimentation, MS, in vitro kinase assay, purfalcamine inhibition, egress assay\",\n      \"pmids\": [\"29716996\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Phosphosites on SERA5 not mapped\", \"The claimed enhancement of proteolytic activity conflicts with evidence that native SERA5 has no protease activity\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Confirming the inactive state structurally: high-resolution structures of the isolated enzyme domain and the prodomain-bound pseudo-zymogen showed the prodomain occludes the catalytic cleft in the conventional reverse orientation, consistent with a maintained inactive zymogen-like state.\",\n      \"evidence\": \"X-ray crystallography at 1.2 Å (domain) and 2.2 Å (pseudo-zymogen)\",\n      \"pmids\": [\"32955133\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether or how the prodomain is removed in vivo is not defined\", \"Does not connect the zymogen state to the egress-regulatory function\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The precise molecular mechanism by which processed, catalytically inactive SERA5 restrains egress timing and organizes merozoite dissemination — and its direct binding target(s) within the vacuole — remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No direct downstream effector or substrate of processed SERA5 identified\", \"Functional meaning of PfCDPK1 phosphorylation and prodomain removal for egress not established\", \"Species divergence in essentiality (dispensable in P. berghei, essential in P. falciparum) unexplained\"],\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0004252\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0030674\", \"supporting_discovery_ids\": [9, 10]},\n      {\"term_id\": \"GO:0005515\", \"supporting_discovery_ids\": [11, 12, 13]},\n      {\"term_id\": \"GO:0004869\", \"supporting_discovery_ids\": [4, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0020003\", \"supporting_discovery_ids\": [1, 5]},\n      {\"term_id\": \"GO:0009986\", \"supporting_discovery_ids\": [7, 8, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0051673\", \"supporting_discovery_ids\": [0, 3, 6, 10]},\n      {\"term_id\": \"GO:0044409\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0090675\", \"supporting_discovery_ids\": [11]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"PfSUB1 (processing protease)\",\n      \"DPAP3 (processing protease)\",\n      \"PfCDPK1 (kinase, phosphorylates SERA5)\",\n      \"host vitronectin (VTN)\",\n      \"PfpTKL pseudokinase (SAM-domain interaction)\"\n    ],\n    \"other_free_text\": [\n      \"Native SERA5 harbors a non-catalytic Ser596 in place of the papain active-site Cys; Ser596Cys restores activity in recombinant protein but Ser596Ala knock-in is phenotypically silent [#9].\",\n      \"Essential in P. falciparum asexual blood stage (refractory to disruption) but the serine-type SERA orthologues are dispensable in P. berghei [#0, #5].\",\n      \"Deletion of SERA4 raises SERA5 mRNA ~2-fold, indicating regulatory/redundancy relationship within the family [#15].\",\n      \"Inhibitory antibody epitopes and the vitronectin-binding site map to intrinsically disordered N-terminal octamer-repeat/serine-rich regions of the P47 fragment [#11, #17].\",\n      \"Peptide/prodomain reagents that engage the SERA5 domain delay parasite development [#16, #18, #19]; the enzyme-inhibition-based interpretations conflict with evidence that native SERA5 lacks protease activity.\",\n      \"Structural analysis indicates the SERA5 active-site architecture is incompatible with ICP-class cysteine protease inhibitor binding [#20].\"\n    ]\n  }\n}","audit_flag":{"gene":"PF3D7_0207600","tier":"IDENTITY_CHECK","verdict":"identity unverified","subtype":"names_other_cards","uniprot_band":"","rules_fired":"R12","issue":"No cited paper names this card; 12 of 21 cited papers name other catalogue genes (PF3D7_0507500, PF3D7_0902800, PF3D7_0207500). The summary may describe one of those genes."},"strains":[{"strain":"Pf3D7","gene_id":"PF3D7_0207600","name":null,"product":"serine repeat antigen 5","uniprot_acc":null,"chromosome":null,"start_pos":null}],"gene_symbol":"SERA5","evaluation":null}